The company announced that it is developing a new biowearable device that will continuously monitor both glucose and ketone levels with one sensor.
Abbott has secured the US Food and Drug Administration’s breakthrough designation for a wearable device that will continuously monitor users' blood glucose and ketone levels.
The announcement comes just months after the company first announced plans for its Lingo line of consumer biowearables, including ketone, lactate and alcohol monitors, at the CES 2022 convention in...
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.
Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.
